UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes

Journal of innate immunity, 2020-05, Vol.12 (3), p.273-274

Mihm, Sabine

2020

Volltextzugriff (PDF)

Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver

World journal of gastroenterology : WJG, 2014-02, Vol.20 (7), p.1807-1821

2014

Volltextzugriff (PDF)

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

Hepatology (Baltimore, Md.), 2006-10, Vol.44 (4), p.896-906

2006

Volltextzugriff (PDF)

Interferon-lambda data

BMC cancer, 2020-11, Vol.20 (1)

2020

Volltextzugriff (PDF)

Interferon-lambda

BMC cancer, 2020-11, Vol.20 (1)

2020

Volltextzugriff (PDF)

Activation of Type I and Type III Interferons in Chronic Hepatitis C

Journal of innate immunity, 2015-01, Vol.7 (3), p.251-259

Mihm, Sabine

2015

Volltextzugriff (PDF)

Enhanced Expression of Interferon-Regulated Genes in the Liver of Patients with Chronic Hepatitis C Virus Infection: Detection by Suppression-Subtractive Hybridization

Journal of Virology, 2001-02, Vol.75 (3), p.1332-1338

2001

Volltextzugriff (PDF)

Hepatitis C Virus, Diabetes and Steatosis: Clinical Evidence in Favor of a Linkage and Role of Genotypes

Digestive diseases (Basel), 2010-01, Vol.28 (1), p.280-284

Mihm, Sabine

2010

Volltextzugriff (PDF)

Relating serum GGT to ALT activity enhances its predictability on treatment outcome in chronic hepatitis C

Hepatology (Baltimore, Md.), 2014-03, Vol.59 (3), p.1213-1214

2014

Volltextzugriff (PDF)

Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes

Hepatology (Baltimore, Md.), 2006-10, Vol.44 (4), p.896-906

2006

Volltextzugriff (PDF)

Hepatic interferon-[lambda]3 (IFNL3) gene expression reveals not to be attenuated in non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 minor allele carriers in chronic hepatitis C

PloS one, 2015-11, Vol.10 (11)

2015

Volltextzugriff (PDF)

Does the interferon‐lambda rather than the interferon‐alpha pathway determine the outcome of hepatitis C virus infection?

Hepatology (Baltimore, Md.), 2014-10, Vol.60 (4), p.1437-1439

2014

Volltextzugriff (PDF)

Ferritin L is the Sole Serum Ferritin Constituent and a Positive Hepatic Acute-Phase Protein

Shock (Augusta, Ga.), 2013-06, Vol.39 (6), p.520-526

2013

Volltextzugriff (PDF)

Host response to hepatitis C virus

Hepatology (Baltimore, Md.), 2005-03, Vol.41 (3), p.679-679

Mihm, Sabine

2005

Volltextzugriff (PDF)

Interferon-α therapy does not modulate hepatic expression of classical type I interferon inducible genes

Journal of medical virology, 2008-11, Vol.80 (11), p.1912-1918

2008

Volltextzugriff (PDF)

Modulation of transcription factor NFχB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply

The FASEB journal, 1995-02, Vol.9 (2), p.246-252

1995

Volltextzugriff (PDF)

Ultra-Rapid Virological Response, Young Age, Low gamma -GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN- alpha sub(2a) Monotherapy

Digestive diseases and sciences, 2011-11, Vol.56 (11), p.3296-3304

2011

Volltextzugriff (PDF)

Ultra-Rapid Virological Response, Young Age, Low [gamma]-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-[alpha].sub.2a Monotherapy

Digestive diseases and sciences, 2011-11, Vol.56 (11)

2011

Volltextzugriff (PDF)

Ultra-Rapid Virological Response, Young Age, Low [gamma]-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-[alpha]^sub 2a^ Monotherapy

Digestive diseases and sciences, 2011-11, Vol.56 (11), p.3296

2011

Volltextzugriff (PDF)

Functions of glutathione and glutathione disulfide in immunology and immunopathology

The FASEB journal, 1994-11, Vol.8 (14), p.1131-1138

1994

Volltextzugriff (PDF)

Fructose-enriched diet induced overexpression of lipocalin-2 in rat fatty liver

Journal of clinical and experimental hepatology, 2013-03, Vol.3 (1), p.S31-S32

2013

Volltextzugriff (PDF)

A reevaluation of the association of hepatitis C virus replicative intermediates with peripheral blood cells including granulocytes by a tagged reverse transcription/polymerase chain reaction technique

Journal of hepatology, 1996-04, Vol.24 (4), p.491-497

1996

Volltextzugriff (PDF)

[13] Effect of reactive oxygen intermediates and antioxidants on proliferation and function of T lymphocytes

Methods in Enzymology, 1994, Vol.234, p.135-151

1994

Volltextzugriff (PDF)

Lack of clinical evidence for involvement of hepatitis C virus interferon-? sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses

Journal of medical virology, 2000-05, Vol.61 (1), p.29-36

2000

Volltextzugriff (PDF)

Ratio of serum ?-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-? in chronic HCV infection

Journal of medical virology, 1999-07, Vol.58 (3), p.227-234

1999

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

ThemaAdult

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(33)
Buchkapitel
(1)

Sprache

Englisch
(34)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(16)
Science & Technology
(16)
Humans
(14)
Animals
(11)
Gastroenterology & Hepatology
(7)
Hepatitis C Virus
(6)
Mice
(6)
Antiviral Agents - Therapeutic Use
(5)
Cells, Cultured
(5)
Male
(5)
Care And Treatment
(4)
Cell Line
(4)
Female
(4)
Health Aspects
(4)
Hepatitis C, Chronic - Drug Therapy
(4)
Interferon
(4)
Interferon-Alpha - Therapeutic Use
(4)
Liver - Metabolism
(4)
Lymphocyte Activation - Drug Effects
(4)
Biochemistry & Molecular Biology
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

COVID-19: Possible Impact of the Genetic Background in IFNL Genes on Disease Outcomes

Diet high in fructose leads to an overexpression of lipocalin-2 in rat fatty liver

Interleukin-29 uses a type 1 interferon-like program to promote antiviral responses in human hepatocytes

Interferon-lambda data

Interferon-lambda

Activation of Type I and Type III Interferons in Chronic Hepatitis C

Enhanced Expression of Interferon-Regulated Genes in the Liver of Patients with Chronic Hepatitis C Virus Infection: Detection by Suppression-Subtractive Hybridization

Hepatitis C Virus, Diabetes and Steatosis: Clinical Evidence in Favor of a Linkage and Role of Genotypes

Relating serum GGT to ALT activity enhances its predictability on treatment outcome in chronic hepatitis C

Interleukin‐29 uses a type 1 interferon‐like program to promote antiviral responses in human hepatocytes

Hepatic interferon-[lambda]3 (IFNL3) gene expression reveals not to be attenuated in non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 minor allele carriers in chronic hepatitis C

Does the interferon‐lambda rather than the interferon‐alpha pathway determine the outcome of hepatitis C virus infection?

Ferritin L is the Sole Serum Ferritin Constituent and a Positive Hepatic Acute-Phase Protein

Host response to hepatitis C virus

Interferon-α therapy does not modulate hepatic expression of classical type I interferon inducible genes

Modulation of transcription factor NFχB activity by intracellular glutathione levels and by variations of the extracellular cysteine supply

Ultra-Rapid Virological Response, Young Age, Low gamma -GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN- alpha sub(2a) Monotherapy

Ultra-Rapid Virological Response, Young Age, Low [gamma]-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-[alpha].sub.2a Monotherapy

Ultra-Rapid Virological Response, Young Age, Low [gamma]-GT/ALT-Ratio, and Absence of Steatosis Identify a Subgroup of HCV Genotype 3 Patients Who Achieve SVR with IFN-[alpha]^sub 2a^ Monotherapy

Functions of glutathione and glutathione disulfide in immunology and immunopathology

Fructose-enriched diet induced overexpression of lipocalin-2 in rat fatty liver

A reevaluation of the association of hepatitis C virus replicative intermediates with peripheral blood cells including granulocytes by a tagged reverse transcription/polymerase chain reaction technique

[13] Effect of reactive oxygen intermediates and antioxidants on proliferation and function of T lymphocytes

Lack of clinical evidence for involvement of hepatitis C virus interferon-? sensitivity-determining region variability in RNA-dependent protein kinase-mediated cellular antiviral responses

Ratio of serum ?-GT/ALT rather than ISDR variability is predictive for initial virological response to IFN-? in chronic HCV infection

Aktive Filter

Suchergebnisse filtern